NIMOTUZUMAB INDUCED HYPERTENSION(NIH): A MAIDEN CASE REPORT


Balaji Ommurugan, Amita Priya, Navin Patil

Abstract


ABSTRACT

                      Nimotuzumab is one among the latest humanized monoclonal antibody targeting against Epidermal Growth Factor Receptor (EGFR). It is approved for Head and neck squamous cancer in India, Srilanka, Cuba and Argentina, for glioma in Cuba, Argentina and Ukraine and Nasopharyngeal cancer in China. Hypertension is most common with Bevacizumab and Cetuximab, which are monoclonal antibodies against EGFR. Hence, we report here a case of Nimotuzumab induced hypertension in a 70-year-old man treated for vocal cord carcinoma.

 

KEYWORDS: Nimotuzumab, Hypertension, EGFR, Adverse effects.


| PDF |

References


Ramakrishnan MS, Eswaraiah A, Crombet T, Piedra P, Saurez G, Iyer H, Arvind AS. Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin. InMAbs 2009 Jan 1 (Vol. 1, No. 1, pp. 41-48). Taylor & Francis.

Robinson ES, Khankin EV, Karumanchi SA, Humphreys BD. Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker. InSeminars in nephrology 2010 Nov 30 (Vol. 30, No. 6, pp. 591-601). WB Saunders.

Fakih, M., & Vincent, M. (2010). Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer. Current Oncology, 17(Suppl 1), S18–S30.

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, RobertsEA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-45.

Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992; 49:2229–32.

Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm.1992; 27:538




About this article

Title

NIMOTUZUMAB INDUCED HYPERTENSION(NIH): A MAIDEN CASE REPORT

DOI

10.22159/ajpcr.2017.v10i4.16868

Date

01-04-2017

Additional Links

Manuscript Submission

Journal

Asian Journal of Pharmaceutical and Clinical Research
Vol 10 Issue 4 April 2017 Page: 8-9

Print ISSN

0974-2441

Online ISSN

2455-3891

Statistics

49 Views | 54 Downloads

Authors & Affiliations

Balaji Ommurugan
Post graduate , Department of Pharmacology, Kasturba Medical college , Manipal university , Manipal.
India

Amita Priya
Post graduate , Department of Pharmacology, Kasturba Medical college , Manipal university , Manipal.

Navin Patil
Assistant Professor, Department of Pharmacology, Kasturba Medical college , Manipal university , Manipal.


Article Tools


Email this article (Login required)
Email the author (Login required)
Share

Refbacks

  • There are currently no refbacks.